MergerLinks Header Logo

Announced

Completed

BD completed the acquisition of the Critical Care Product Group of Edwards Lifesciences for $4.2bn.

Synopsis

BD, a global medical technology company, completed the acquisition of the Critical Care Product Group of Edwards Lifesciences, a provider of advanced monitoring solutions, for $4.2bn. "Critical Care expands BD's portfolio of smart connected care solutions with its growing set of leading monitoring technologies, advanced AI-enabled clinical decision tools and robust innovation pipeline that complement BD's existing technologies serving operating rooms and intensive care units," Tom Polen, BD Chairman, CEO and President.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US